
30.92 Delayed Data As of Feb 03 | ![]() Today’s Change | 13.84 Today|||52-Week Range 62.49 | +4.67% Year-to-Date |
SECTOR Health Technology | INDUSTRY Biotechnology | MARKET CAP $1.3B |
Cassava Sciences, Inc. 6801 North Capital of Texas Highway Austin Texas 78731 |
Remi Barbier | Chairman, President & Chief Executive Officer |
Eric J. Schoen | Chief Financial Officer |
James W. Kupiec | Chief Medical Officer |
Michael Zamloot | Senior Vice President-Technical Operations |
George B. Thornton | Senior Vice President-Technology |